WNDM - Wound Management Technologies, Inc.

Other OTC - Other OTC Delayed price. Currency in USD

Wound Management Technologies, Inc.

1200 Summit Avenue
Suite 414
Fort Worth, TX 76102
United States

IndustryMedical Appliances & Equipment
Full-time employees10

Key executives

Mr. J. Michael CarmenaChief Financial Officer8.64kN/A62
Ms. Cathy BradshawPres of Wound Care Innovations LLC120kN/A65
Dr. Jane A. Fore M.D.Chief Medical OfficerN/AN/AN/A
Karin K. DelappControllerN/AN/AN/A
Mandy MuseSec.N/AN/AN/A
Amounts are as of 31 December 2016, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Wound Management Technologies, Inc., together withs itssubsidiaries, develops, markets, and distributes collagen-based wound care products to physicians, clinics, and hospitals in the United States. The company offers CellerateRX, a medical device for use on various acute and chronic wounds in gel and powder form. It also holds patents for a resorbable bone wax and delivery system for orthopedic bone void fillers. The company was formerly known as MB Software, Inc. and changed its name to Wound Management Technologies, Inc. in May 2008. Wound Management Technologies, Inc. was founded in 1982 and is based in Fort Worth, Texas.

Corporate governance

Wound Management Technologies, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes